mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
0.0001 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.04 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.5 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |